Sonnet BioTherapeutics I... (SONN)
1.54
0.00 (0.00%)
At close: Feb 28, 2025, 3:59 PM
1.50
-2.60%
After-hours: Feb 28, 2025, 04:56 PM EST
Sonnet BioTherapeutics Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
| Net Income | -7.44M | -18.83M | -29.72M | -24.98M | -24.27M | -4.87M | -6.86M | -6.79M | -4.27M | -14.46M | -5.48M | -5.19M | -3.17M | -1.1M | -1.01M | -813.7K | -2.24M |
| Depreciation & Amortization | 83.11K | 75.75K | 93.26K | 95.16K | 58.31K | 2.16M | 1.82M | 2.28M | 2.34M | 2.36M | 1.59M | 622.27K | 383.45K | 87.62K | 11.08K | 11.48K | 11.2K |
| Stock-Based Compensation | 231.19K | 248.63K | 876.37K | 1.38M | 370.06K | 430K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Working Capital | -1.95M | -484.31K | -877.58K | -637.73K | 1.23M | 639.02K | -74.29K | 208.02K | -1.21M | -277.67K | 893.81K | -41.81K | -187.49K | -209.75K | -4.43K | -274.62K | -105.95K |
| Other Non-Cash Items | 413.95K | 282K | 971.48K | 623.00 | 6.83M | 516.23K | 3.03M | 6.66M | 4.71M | 6.63M | 2.56M | 1.43M | 5.03K | 307.74K | 205.6K | 439.61K | 1.33M |
| Deferred Income Tax | n/a | n/a | n/a | -125.5K | n/a | -702.59K | -779.36K | -706.2K | 131.78K | 94.53K | -653.83K | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | -1.9M | -3.12M | 93.46K | 1.09M | 1.4M | 2.13M | 2.62M | 1.31M | 25.23K | 277.67K | 961.28K | 436.54K | 424.17K | -336.37K | 34.57K | -273.87K | 49.17K |
| Operating Cash Flow | -8.61M | -21.34M | -27.69M | -22.55M | -15.61M | -2.23M | -1.11M | -724.43K | -509.16K | -5.36M | -1.03M | -2.7M | -2.35M | -1.04M | -760.31K | -636.48K | -849.9K |
| Capital Expenditures | n/a | -443.25K | -896.48K | -3.62K | -76.18K | -2.39M | -1.7M | -1.63M | -1.19M | -1.8M | -1.97M | -3.66M | -1.17M | -388.11K | -4.52K | -7.44K | -1.82K |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | 1.44M | 770K | 1.19M | 751.46K | -9.02M | -322.47K | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -674.08K | -1.2M | -1.29M | -46.33K | -94K | -120K |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8.9K | 500K | 19.75K | n/a | 16.6K | 170.33K | 297.9K | 749.57K | 101.05K |
| Other Investing Acitivies | -12K | -443.25K | -810.23K | n/a | n/a | -1.49M | -322.28K | 461.16K | n/a | -169.64K | 101.47K | 267.1K | -256.28K | -150.47K | -680 | n/a | -279.05K |
| Investing Cash Flow | -12K | -443.25K | -896.48K | -3.62K | -76.18K | -2.44M | -1.25M | -439.3K | -430.82K | -10.49M | -2.17M | -4.07M | -2.62M | -1.65M | 246.37K | 648.12K | -299.82K |
| Debt Repayment | n/a | -748 | n/a | n/a | 128.68K | n/a | n/a | 68.65K | -279.16K | 1.87M | 1.82M | 2.82M | -1.07M | 2.78M | 557.58K | -100K | 378.99K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 2.6M | 849.00 | 2.17M | 42.83M | 3.81M | -526.06K | 383.08K | n/a | n/a | 348.11K | n/a | n/a | 43.72K | n/a | n/a | n/a | n/a |
| Financial Cash Flow | 6.49M | 21.01M | 4.01M | 42.83M | 23.01M | 2.26M | 1.32M | 1.36M | -21.98K | 17.14M | 3.03M | 5.89M | 6.03M | 2.8M | 557.58K | -23.42K | 1.16M |
| Net Cash Flow | -2.12M | -778.62K | -24.57M | 20.27M | 7.31M | 30.23K | 85.62K | 169.92K | -961.96K | 1.28M | -196.87K | -781.11K | 1.08M | 105.92K | n/a | n/a | n/a |
| Free Cash Flow | -8.61M | -21.79M | -28.58M | -22.56M | -15.69M | -4.62M | -2.81M | -2.35M | -1.7M | -7.16M | -2.97M | -6.4M | -3.53M | -1.43M | -764.83K | -643.92K | -851.72K |